Impact of rituximab therapy on endothelial function and other markers of atherosclerosisin patients with active rheumatoid arthritis
Endothelial dysfunction plays a key role in the pathogenesis of atherosclerosis. An increased cardiovascular risk in patients with rheumatoid arthritis (RA) suggests that inflammation is of importance for the occurrence and progression of atherosclerosis. Rituximab (RTM, monoclonal antibodies to CD2...
| الحاوية / القاعدة: | Научно-практическая ревматология |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
IMA PRESS LLC
2010-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://rsp.mediar-press.net/rsp/article/view/953 |
